The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Cho, E. C., Xie, J., Wurm, P. A., & Xia, Y. (2009) · Nano Letters · doi:10.1021/nl803487r · Cited by 819
De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity
Javadpour, M. M., Juban, M. M., Lo, W.-C. J., Bishop, S. M., Alberty, J. B., Cowell, S. M., Becker, C. L., & McLaughlin, M. L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509410 · Cited by 597
Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 575
Nam, H. Y., Kwon, S. M., Chung, H., Lee, S.-Y., Kwon, S.-H., Jeon, H., Kim, Y., Park, J. H., Kim, J., Her, S., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.018 · Cited by 564
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
Du, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907210 · Cited by 520
Non-viral gene therapy: polycation-mediated DNA delivery
Thomas, M., & Klibanov, A. M. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1321-8 · Cited by 482
Genetic heterogeneity and cancer drug resistance
Turner, N. C., & Reis-Filho, J. S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70335-7 · Cited by 454
Khalil, I. A., Kogure, K., Futaki, S., & Harashima, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m503202200 · Cited by 390
Selective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Jiang, T., Zhang, Z., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 359
Lee, Y., Ishii, T., Cabral, H., Kim, H. J., Seo, J., Nishiyama, N., Oshima, H., Osada, K., & Kataoka, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900064 · Cited by 351
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347
Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery
Zhou, Z., Shen, Y., Tang, J., Fan, M., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900825 · Cited by 311
Mitochondrial dysfunction in cancer
Modica-Napolitano, J. S., & Singh, K. K. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.027 · Cited by 299
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.009 · Cited by 279
Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.018 · Cited by 255
Multistage pH‐Responsive Liposomes for Mitochondrial‐Targeted Anticancer Drug Delivery
Mo, R., Sun, Q., Xue, J., Li, N., Li, W., Zhang, C., & Ping, Q. (2012) · Advanced Materials · doi:10.1002/adma.201201498 · Cited by 244
Lee, Y., Miyata, K., Oba, M., Ishii, T., Fukushima, S., Han, M., Koyama, H., Nishiyama, N., & Kataoka, K. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800963 · Cited by 229
Wang, X.-X., Li, Y.-B., Yao, H.-J., Ju, R.-J., Zhang, Y., Li, R.-J., Yu, Y., Zhang, L., & Lu, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.029 · Cited by 216
Zhou, J., Zhao, W.-Y., Ma, X., Ju, R.-J., Li, X.-Y., Li, N., Sun, M.-G., Shi, J.-F., Zhang, C.-X., & Lu, W.-L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.078 · Cited by 216
Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes
Sharma, A., & Straubinger, R. M. (1994) · Pharmaceutical Research · doi:10.1023/a:1018994111594 · Cited by 215
Mechanisms of Multidrug Resistance in Cancer Treatment
Harris, A. L., & Hochhauser, D. (1992) · Acta Oncologica · doi:10.3109/02841869209088904 · Cited by 207
Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
Ferlini, C., Cicchillitti, L., Raspaglio, G., Bartollino, S., Cimitan, S., Bertucci, C., Mozzetti, S., Gallo, D., Persico, M., Fattorusso, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0540 · Cited by 165
Mironov, S. L., Ivannikov, M. V., & Johansson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409819200 · Cited by 164
Yao, H.-J., Ju, R.-J., Wang, X., Zhang, Y., Li, R., Yu, Y., Zhang, L., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.038 · Cited by 151
Zhang, L., Yao, H.-J., Yu, Y., Zhang, Y., Li, R., Ju, R.-J., Wang, X., Sun, M., Shi, J., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.055 · Cited by 129
A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity
Law, B., Quinti, L., Choi, Y., Weissleder, R., & Tung, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0509 · Cited by 127
Yamada, Y., Akita, H., Kogure, K., Kamiya, H., & Harashima, H. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.003 · Cited by 123
Mo, R., Sun, Q., Li, N., & Zhang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.030 · Cited by 122
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems
Weissig, V., & Torchilin, V. P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00131-4 · Cited by 117
Kumar, A. P., Garcia, G. E., & Slaga, T. J. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1046 · Cited by 88
CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells
Liu, J., Ma, H., Wei, T., & Liang, X. (2012) · Chemical Communications · doi:10.1039/c2cc31697h · Cited by 76
In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer
Kim, C.-E., Lim, S.-K., & Kim, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.066 · Cited by 62
Tamaru, M., Akita, H., Fujiwara, T., Kajimoto, K., & Harashima, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.024 · Cited by 61
Mechanisms of intrinsic and acquired resistance to kinase‐targeted therapies
Bagrodia, S., Smeal, T., & Abraham, R. T. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12007 · Cited by 59
Cationic amphiphilic polyproline helix P11LRR targets intracellular mitochondria
Li, L., Geisler, I. M., Chmielewski, J. A., & Cheng, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.012 · Cited by 59
Self-citationChang, J., Xu, X., Li, H., Jian, Y., Wang, G., He, B., & Gu, Z. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201202503 · Cited by 51
Self-citationSugahara, S.-I., Kajiki, M., Kuriyama, H., & Kobayashi, T. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.632 · Cited by 48
Li, L., Song, H., Luo, K., He, B., Nie, Y., Yang, Y., Wu, Y., & Gu, Z. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.051 · Cited by 47
Self-citationZhang, Z., Liu, Z., Ma, L., Jiang, S., Wang, Y., Yu, H., Yin, Q., Jingbin, C., & Li, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400039j · Cited by 31
Lu, C., Zhao, D., Wang, S., Wang, Y., Wang, Y., Gao, H., Ma, J., & Wu, G. (2014) · RSC Advances · doi:10.1039/c3ra47353h · Cited by 23
Gerbert, B., Bleecker, T., Maguire, B. T., & Caspers, N. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02599211 · Cited by 21
Solit, D. B., & Janne, P. A. (2012) · Nature · doi:10.1038/483044a · Cited by 16
Cited by
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Stimuli‐responsive liposomes for drug delivery
Lee, Y., & Thompson, D. H. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1450 · Cited by 579
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Wang, P., Wang, H., Huang, Q., Peng, C., Yao, L., Chen, H., Qiu, Z., Wu, Y., Wang, L., & Chen, W. (2019) · Theranostics · doi:10.7150/thno.30716 · Cited by 494
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Metadata
- Authors
- Jiang, L., Li, L., He, X., Yi, Q., He, B., Cao, J., Pan, W., & Gu, Z.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 52
- Pages
- 126-139
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2021651355
- Cited by
- 294
- References
- 59
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.